Home › VOLITIONRX LTD. › Nieuws › VolitionRx - On the cusp of a breakthrough in testing for sepsis VOLITIONRX LTD. OverzichtKoersenGrafiekSignalenNieuwsAnalysesWarrantsProfielWall - USD (-) - 15 min. vertraagde - NYSE MKT Aandelen Open: - Verschil: - Volume: - Laag: - Hoog: - Hoog - Laag: - Type: Aandelen Ticker: VNRX ISIN: Overzicht Koersen Grafiek Signalen Nieuws Analyses Warrants Profiel Wall VolitionRx - On the cusp of a breakthrough in testing for sepsis 173 0 VolitionRx (NYSE American: VNRX) is a multinational epigenetics company that applies its Nucleosomics platform through its ... Edison